For those long-term holders - my humble suggestion: ignore the short term gyrations in the price and the day-trade banter of failed expectations in share price.
Look at the big picture: Every announcement to date regarding PAT- DX-1, keeps confirming the potential of this novel antibody for the treatment of aggressive cancers in the DDR space: as a single agent or conjugated to nanoparticles or in combination therapy. Indeed the potential for PAT DX-1 is huge and should be viewed as game-changing platform DDR therapy in the most broadest sense.
For those who have held the stock since this time last year - the price has steadily climbed from less than 0.5c to around the 5c mark.
Moreover, the major shareholders (Calder and Stork) and now Maquarie and Mason-Stevens continue to increase their holdings.
We should be taking our cues from the major shareholders and the PAT DX-1 announcements to date "as a whole", not from the short-term disappointments (quite often bordering on the neurotic) of the the day-traders.
- Forums
- ASX - By Stock
- PAB
- Ann: Preliminary PAT-DX1 pharmacokinetics
Ann: Preliminary PAT-DX1 pharmacokinetics, page-45
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 5101591 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1558945 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 5101591 | 0.006 |
18 | 8630976 | 0.005 |
7 | 4425000 | 0.004 |
6 | 2930016 | 0.003 |
2 | 4520000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 1558945 | 5 |
0.008 | 2057547 | 3 |
0.009 | 133332 | 1 |
0.010 | 1412000 | 3 |
0.011 | 1080000 | 2 |
Last trade - 16.12pm 17/07/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
Day chart unavailable